Project
东曜药业与国内外制药公司开展多元的战略合作,提供药物开发生产一站式CDMO解决方案,帮助客户加速生物药特别是抗体偶联药(ADC)的开发和生产,赋能产业高质量发展。
- Yes
- IPO
- Bio-Tech
- Technology
- Hedge Funds
- Manufacturing
- Private Project
- R&D Cooperation
- Fund Management
- Wealth Management
- Financial Services
- Open for Negotiation
- Minority Shareholdings
- 50,000,001 USD or above
- Institutional Investment
- Feasibility Study Completed
- Private Equity & Venture Capital
Author